John Whitt, DPM
Foot & Ankle Surgery · Waterloo, IANPI 1851702005
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Stryker accounts for 69.3% of it on its own, with 10 other manufacturers making up the rest.
Across 111 payments — averaging $30.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Organogenesis Inc.$290
- Smith+Nephew$219
- Treace Medical Concepts, Inc.$200
- Johnson & Johnson$100
- Kuros Biosciences USA, Inc$74
- plus $145 from 5 others
What the payments were for
- Speaking & faculty fees$602%
- Food & beverage$3,28398%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 51 | $2,315 |
| Organogenesis Inc. | 26 | $290 |
| Smith+Nephew | 20 | $219 |
| Treace Medical Concepts, Inc. | 4 | $200 |
| Johnson & Johnson | 3 | $100 |
| Kuros Biosciences USA, Inc | 1 | $74 |
| Bone Support Inc. | 1 | $66 |
| Osiris Therapeutics Inc. | 2 | $30 |
| Prism Medical | 1 | $20 |
| Medela LLC | 1 | $18 |
| KCI USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUGMENT INJECTABLE$637
- PROSTEP MICA$324
- FIXOS$322
- VARIAX$322
- ORTHOLOC 3DI$293
- 7 X 23MM CITRELOCK IMPLANT$174
- PANGEA$162
- PROstep$160
- TRAUMA$134
How this compares
$3,343 in reported general payments places this provider in the 55th percentile of 112 foot & ankle surgery providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 28 | $1,215 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $418 |
| Doxycycline Monohydrate | 36 | $402 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $219 |
| Meloxicam | 39 | $149 |
| Cephalexin | 32 | $109 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Waterloo
- Gregory FooteWaterloo$35K
- Samuel BernardWaterloo$11K
- Kelsey SukovatyWaterloo$10K
- Michael OwensWaterloo$9K
- Gregory LantzWaterloo$9K
- Maliha ArzumandWaterloo$5K
- Ryan BauermeisterWaterloo$5K
- Kathie WhittWaterloo$3K
- Michael LeeDes Moines$2.1M
- Phinit PhisitkulSioux City$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.